ClinicalTrials.Veeva

Menu

Impact of Vaccenic Acid Consumption on the Metabolism of Saturated Fatty Acids: Relationship With Cardiovascular Risk Factors (TRANSQUAL WPC)

I

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

Status

Completed

Conditions

Cardiovascular Disease

Treatments

Dietary Supplement: Ruminant trans fatty acid enriched diet - medium ratio
Dietary Supplement: Ruminant trans fatty acid enriched diet - lowest ratio
Dietary Supplement: Ruminant trans fatty acid enriched diet - highest ratio

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The investigators' project has for principal objective to evaluate the impact of three specific ruminant milk fats with a Trans Fatty Acid content ranging from 2.9% to 12.2% obtained by modification of the cow's diet on cardiovascular risk factors in healthy subjects.

Full description

111 healthy, normolipemic men and women (18y to 50y) have been recruited for a monocentric, randomised, double-blind, controlled 4-week study. All the volunteers consumed 3 experimental products (butter, dessert cream and cakes) made with one of the 3 specific milk fats up to 55 g fat/day.

Enrollment

107 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • HDL cholesterol, g/L > 0.4
  • Triacylglycerol g/L <1.50
  • LDL Cholesterol g/L <1.60
  • Waist size < 94 cm (men) or 80 cm (women)
  • Affiliated to National Health Insurance
  • Normal blood pressure (diastolic <90 mm Hg, systolic <140 mm Hg)
  • For women: effective contraception
  • Subject giving his/her written informed consent
  • Subject willing to comply with the study procedures

Exclusion criteria

  • Reported food allergies
  • Currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study
  • Hepatic or renal impairments
  • Positive serologies to HIV or HCV,
  • Blood donation done less than 2 months before the start of the study
  • Chronic pathologies
  • Refusal to be registered on the National Volunteers Data file
  • Being in exclusion on the National Volunteers Data file

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

107 participants in 3 patient groups

A
Experimental group
Description:
Arms A: the lowest R-TFA/SFA ratio obtained from dairy cows in Winter period
Treatment:
Dietary Supplement: Ruminant trans fatty acid enriched diet - lowest ratio
B
Experimental group
Description:
Arms B: the medium R-TFA/SFA ratio obtained from dairy cows feeding with Winter diet supplemented with 4.1% flax seed.
Treatment:
Dietary Supplement: Ruminant trans fatty acid enriched diet - medium ratio
C
Experimental group
Description:
Arms C: the highest R-TFA/SFA ratio obtained from dairy cows feeding with Winter diet supplemented with 9% flax seed.
Treatment:
Dietary Supplement: Ruminant trans fatty acid enriched diet - highest ratio

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems